Meeder Asset Management Inc Acer Therapeutics Inc. Transaction History

Meeder Asset Management Inc

  • $1.42 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
$1.53 - $4.53 $1,023 - $3,030
-669 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$1.18 - $5.86 $1,033 - $5,133
-876 Reduced 56.7%
669 $1,000
Q4 2019

Feb 13, 2020
SELL
$2.85 - $4.2 $15,811 - $23,301
-5,548 Reduced 78.22%
1,545 $6,000
Q3 2019

Oct 17, 2019
BUY
$1.95 - $3.93 $13,831 - $27,875
7,093 New
7,093 $21,000

Others Institutions Holding ACER

# of Institutions
1
Shares Held
365
Call Options Held
0
Put Options Held
0
View Full List

About Acer Therapeutics Inc.

ACER Quotes by TradingView
  • Ticker ACER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,100,000
  • Description
  • Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...
More about ACER
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email